| 3.99 Data as of May 23 | +0.05 / +1.27%Today’s Change | 3.09 Today|||52-Week Range 23.43 | -13.82% Year-to-Date |
The 1 analysts offering 12-month price forecasts for Rosetta Genomics Ltd have a median target of 16.00, with a high estimate of 16.00 and a low estimate of 16.00. The median estimate represents a +301.00% increase from the last price of 3.99.

The current consensus among 1 polled investment analysts is to Hold stock in Rosetta Genomics Ltd. This rating has held steady since May, when it was unchanged from a rating.Move your mouse over past
months for detail

Move your mouse over a quarter or year to see how estimates have changed over time.




